CGON logo

CG Oncology, Inc. (CGON) EBIT

Annual EBIT:

-$114.67M-$59.22M(-106.80%)
December 31, 2024

Summary

  • As of today, CGON annual earnings before interest & taxes is -$114.67 million, with the most recent change of -$59.22 million (-106.80%) on December 31, 2024.
  • During the last 3 years, CGON annual EBIT has fallen by -$102.28 million (-825.62%).
  • CGON annual EBIT is now -825.62% below its all-time high of -$12.39 million, reached on December 1, 2021.

Performance

CGON EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

Quarterly EBIT:

-$51.13M-$2.39M(-4.90%)
September 30, 2025

Summary

  • As of today, CGON quarterly earnings before interest & taxes is -$51.13 million, with the most recent change of -$2.39 million (-4.90%) on September 30, 2025.
  • Over the past year, CGON quarterly EBIT has dropped by -$22.83 million (-80.70%).
  • CGON quarterly EBIT is now -448.89% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

CGON Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

TTM EBIT:

-$180.12M-$22.83M(-14.52%)
September 30, 2025

Summary

  • As of today, CGON TTM earnings before interest & taxes is -$180.12 million, with the most recent change of -$22.83 million (-14.52%) on September 30, 2025.
  • Over the past year, CGON TTM EBIT has dropped by -$84.57 million (-88.51%).
  • CGON TTM EBIT is now -1833.69% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

CGON TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CGON EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-106.8%-80.7%-88.5%
3Y3 Years-825.6%-448.9%-1833.7%
5Y5 Years-825.6%-448.9%-1833.7%

CGON EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-825.6%at low-448.9%at low-1833.7%at low
5Y5-Year-825.6%at low-448.9%at low-1833.7%at low
All-TimeAll-Time-825.6%at low-448.9%at low-1833.7%at low

CGON EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$51.13M(-4.9%)
-$180.12M(-14.5%)
Jun 2025
-
-$48.74M(-15.5%)
-$157.29M(-17.0%)
Mar 2025
-
-$42.20M(-10.9%)
-$134.40M(-17.2%)
Dec 2024
-$114.67M
-$38.05M(-34.5%)
-$114.67M(-20.0%)
Sep 2024
-
-$28.30M(-9.4%)
-$95.55M(-42.1%)
Jun 2024
-
-$25.85M(-15.1%)
-$67.25M(-25.2%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$22.47M(-18.7%)
-$53.73M(-71.9%)
Dec 2023
-$55.45M(-57.3%)
-$18.93M(-53.6%)
-$31.26M(-44.4%)
Jun 2023
-
-$12.33M(-32.3%)
-$21.64M(-132.3%)
Dec 2022
-$35.25M(-184.5%)
-
-
Dec 2022
-
-$9.31M
-$9.31M
Dec 2021
-$12.39M
-
-

FAQ

  • What is CG Oncology, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual EBIT year-on-year change?
  • What is CG Oncology, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly EBIT year-on-year change?
  • What is CG Oncology, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. TTM EBIT year-on-year change?

What is CG Oncology, Inc. annual earnings before interest & taxes?

The current annual EBIT of CGON is -$114.67M

What is the all-time high annual EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual earnings before interest & taxes is -$12.39M

What is CG Oncology, Inc. annual EBIT year-on-year change?

Over the past year, CGON annual earnings before interest & taxes has changed by -$59.22M (-106.80%)

What is CG Oncology, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of CGON is -$51.13M

What is the all-time high quarterly EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly earnings before interest & taxes is -$9.31M

What is CG Oncology, Inc. quarterly EBIT year-on-year change?

Over the past year, CGON quarterly earnings before interest & taxes has changed by -$22.83M (-80.70%)

What is CG Oncology, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of CGON is -$180.12M

What is the all-time high TTM EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high TTM earnings before interest & taxes is -$9.31M

What is CG Oncology, Inc. TTM EBIT year-on-year change?

Over the past year, CGON TTM earnings before interest & taxes has changed by -$84.57M (-88.51%)
On this page